Clinical Trial Update: Treatment of Mild-moderate Clostridium Difficile Infection (CDI) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for treatment of mild-to-moderate Clostridium difficile infection (CDI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Snippet

Sponsor: ImmuniMed Inc. | Conditions: Clostridium Difficile Infection (CDI) | Phase 2 | Status: UNKNOWN